comparemela.com

Page 3 - Antoine Yver News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Centessa Pharmaceuticals (NASDAQ:CNTA) Stock Price Down 5 5%

Shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA – Get Free Report) were down 5.5% on Monday . The stock traded as low as $6.81 and last traded at $6.90. Approximately 62,297 shares changed hands during trading, a decline of 62% from the average daily volume of 162,998 shares. The stock had previously closed at $7.30. Analyst […]

Centessa Pharmaceuticals (NASDAQ:CNTA) Stock Price Down 5 3%

Centessa Pharmaceuticals plc (NASDAQ:CNTA – Get Free Report) shares fell 5.3% during mid-day trading on Tuesday . The company traded as low as $7.50 and last traded at $7.51. 45,999 shares changed hands during mid-day trading, a decline of 72% from the average session volume of 164,245 shares. The stock had previously closed at $7.93. […]

Centessa Pharmaceuticals (NASDAQ:CNTA) Trading Down 5 3%

Shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA – Get Free Report) dropped 5.3% during trading on Tuesday . The stock traded as low as $7.50 and last traded at $7.51. Approximately 45,999 shares were traded during mid-day trading, a decline of 72% from the average daily volume of 164,245 shares. The stock had previously closed at […]

Centessa Pharmaceuticals Announces Dosing of First Subject in Registrational PRESent-2 Study Evaluating SerpinPC for the Treatment of Hemophilia B without Inhibitors

Centessa Pharmaceuticals Announces Dosing of First Subject in Registrational PRESent-2 Study Evaluating SerpinPC for the Treatment of Hemophilia B without Inhibitors
finanzen.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.ch Daily Mail and Mail on Sunday newspapers.

Centessa Pharmaceuticals plc (NASDAQ:CNTA) Given Consensus Rating of Moderate Buy by Brokerages

Centessa Pharmaceuticals plc (NASDAQ:CNTA – Free Report) has been assigned a consensus rating of “Moderate Buy” from the six research firms that are currently covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and four have issued a buy recommendation on […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.